Amgen 2Q 2Q Revenue: $3.7 billion (-1%) 2Q Earnings: $1.3 billion (+40%) YTD Revenues: $7.0 billion (-5%) YTD Earnings: $2.3 billion (+14%) Comments: Product sales in the quarter were down 2% to $3.6 billion. Sales in the U.S. were flat at $2.8 billion, while international sales were down 6% to $801 million. The decline reflects the unfavorable impact of foreign exchange, which totaled approximately $103 million. Worldwide sales of Aranesp were down 16% to $693 million. Epogen sal...